The Primary Care Clinical Trials Network (PCCTN) provides sponsors and investigators one-stop access to a large patient population presently followed in the New York Presbyterian Hospital Healthcare System. The core of PCCTN is several hospital-based, high volume, primary care internal medicine practices along with numerous links to community hospitals and physicians in the tri-state area.
The Co-Directors of PCCTN, B. Robert Meyer, M.D. and Steven Shea, M.D. and their Advisory Council have many years of experience in conducting sponsored clinical research and in enrolling subjects in investigative studies. This group of medical professionals is expert in conceptualizing, designing and initiating clinical trials, and they are also authorities in clinical pharmacology.
A vital component of the PCCTN is the Associates in Internal Medicine (AIM), the faculty practice of the Division of General Medicine at the Columbia Presbyterian Center of New York Presbyterian Hospital. Together, Dr. Shea, Director of the Division of General Medicine, and Dr. Rafael Lantigua, Associate Director, have more than twenty-five years of experience in patient care. Dr. Walter R. Palmas-Mellinger, Assistant Professor of Clinical Medicine in the Division of General Medicine, is AIMs lead physician in the PCCTN. Approximately 60% of AIMs patients are Latino, 25% African-American, and 15% non-Hispanic white, totalling over 55,000 outpatient visits yearly. Clinical research at AIM is conducted in populations speaking English and Spanish.
Areas of Therapeutic Focus
Urinary Tract Infections
Cornell Internal Medicine Associates (C.I.M.A.) is the primary academic teaching Internal Medicine Practice at the New York Weill Cornell Center of New York Presbyterian Hospital. Dr. Meyer, the Co-Director of the PCCTN, is also the Director of C.I.M.A. The patient population consists of 30% Latino, 30% African-American, 10% Asian, and 30% Caucasian, totalling over 52,000 outpatient visits yearly. C.I.M.A. has a sophisticated clinical information system that is a uniquely complete repository of laboratory testing, radiologic and pathologic testing results, drug treatment histories, ICD-9 diagnostic coding, visit history and clinician notes for all patients.
AIM and C.I.M.A., along with a vibrant network of community hospitals and practitioners, form the foundation for the PCCTN. Our diverse and abundant patient base, strong academic foundation and unsurpassed medical experience in treatment and research offer the sponsor and the investigator a superb opportunity for clinical study.
B. Robert Meyer, M.D. (at left) Co-Director of PCCTN, Professor of Clinical Medicine and Associate Chairman for Clinical Affairs in the Department of Medicine, Weill Medical College of Cornell University and Director of Cornell Internal Medicine Associates, New York Weill Cornell Center of New York Presbyterian Hospital. He was previously the Chief of the Division of Clinical Pharmacology at North Shore University Hospital where he conducted clinical research concerning techniques for transdermal administration of peptides and proteins. Dr. Meyer has been the recipient of many grants including a Pharmaceutical Manufacturers Association Foundation Clinical Pharmacology Development grant. Dr. Meyer is an Assistant Editor of Clinical Pharmacology and Therapeutics, a reviewer for numerous journals, and the author of a number of papers and book chapters in the area of clinical pharmacology and geriatric clinical pharmacology.
Steven Shea, M.D., M.S. (at right) Co-Director of PCCTN, Hamilton Southworth Professor of Medicine and Director of the Division of General Medicine at the Columbia University College of Physicians and Surgeons. He is also on the faculty of the Columbia University School of Public Health in the Division of Epidemiology. He is the principal investigator for multiple grants from the NIH. Dr. Shea has published extensively in the areas of cardiovascular epidemiology and medical informatics, is a member of the Editorial board of the American Journal of Medicine and has been a member of study sections at both the Agency for Health Care Policy and Research (AHCPR) and the National Heart, Lung and Blood Institute (NHLBI).
Mark S. Lachs, M.D., M.P.H. Associate Professor of Medicine and Chief of the Division of Geriatrics and Gerontology, Weill Medical College of Cornell University, Associate Professor of Clinical Epidemiology and Health Services Research in the Cornell School of Graduate Medical Sciences and Attending Physician at New York Presbyterian Hospital. Dr. Lachs leads two NIH grants for the study of elder abuse and precipitants of functional decline in older women and is the author of numerous articles on geriatrics.
Rafael Lantigua, M.D. Professor of Clinical Medicine, Associate Director of the Division of General Medicine, Columbia University College of Physicians and Surgeons, Director for Medical Research at Columbias Stroud Center for Geriatric Research and Medical Director of the Associates of Internal Medicine (AIM) Practice, New York Presbyterian Hospital. Dr. Lantigua is known nationally for his research on minority aging and is the principal investigator for Columbia Universitys Resource Center for Minority Aging Research funded by the National Institute on Aging.
Marcus M. Reidenberg, M.D. Professor of Medicine and of Pharmacology, and Assistant Dean, Weill Medical College of Cornell University. Dr. Reidenberg is the Chief of the Division of Clinical Pharmacology at Cornell. He ranks among the most influential and respected individuals in the field of Clinical Pharmacology and since 1985 has served as the editor of Clinical Pharmacology and Therapeutics.